People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...
Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVXâ„¢ (suzetrigin ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...
Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...
A sexy calculator? You’ve got to be kidding. Though indisputably necessary, it’s hard even to remember a time when they existed. Today we just instinctively tap an app on our phone for some ...
Following this news, shares of Vertex fell 12% in morning trading on the same day. To obtain additional information, go to: or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com ...
Following this news, shares of Vertex fell 12% in morning trading on the same day. To obtain additional information, go to: or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com ...